Skip to main content

Table 2 Signs and symptoms history of patients with Gaucher disease

From: A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China

Patient number

1

2

3

4

Sex

M

M

M

F

Age

2

1

12

1

Height (cm)

88

81

130

73

Weight (kg)

15

14

33.5

8.8

Splenomegaly(palpation)

+

+

+

Hepatomegaly(palpation)

+

+

+

Splenomegaly(US)

+

+

megalosplenia

megalosplenia

Hepatomegaly (US)

+

+

+

Development delay

+

CNS involvement

History of bone pain

+

History of fracture

PLT (× 109/L)

71

157

71

54

Hb (g/L)

105

74

121

87

WBC (×109/L)

4.17

6.85

4.83

6.55

RBC (× 1012/L)

3.99

3.9

5.02

3.46

ALT (U/L)

21.7

12.8

18

92

AST (U/L)

62.8

81.3

41

134

HDL (mmol/L)

0.39

0.4

ND

0.25

Ferritin (ng/ml)

342.21

189.3

ND

ND

GD cell in bone marrow

+

+

+

+

DBS value (nmol/h.ml)

0

3.01

0.07

2

Enzyme level in leukocytes (nmol/h.mg)

1.56

1

2.6

0.38

GBA mutation

N370S/L444P + A456P

R131C/L264I

R48W/R163X

A100Cfs*7/D399E

  1. PLT: platelets; Hb: haemoglobin;WBC: white blood cell; ALT: Alanine aminotransferase; AST: aspartate aminotransferase; HDL: high density lipoprotein; ND: not detected; DBS: dried blood spot